Rhesus lymphocryptovirus latent membrane protein 2A activates β-catenin signaling and inhibits differentiation in epithelial cells

Virology

Volumn 377, Issue 2, 2008, Pages 273-279

  Siler, Catherine A ^a   Raab Traub, Nancy ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

catenin; Differentiation; EBV; Keratinocytes; LMP2; Rhesus LCV

Indexed keywords

BETA CATENIN; GLYCOGEN SYNTHASE KINASE 3BETA; LATENT MEMBRANE PROTEIN 2A; MEMBRANE PROTEIN; MUTANT PROTEIN; PROTEIN KINASE B; TELOMERASE; VIRUS PROTEIN;

ARTICLE; CELL DIFFERENTIATION; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVATION; EPITHELIUM CELL; HERPES VIRUS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; WILD TYPE;

ANIMALS; BETA CATENIN; CELL DIFFERENTIATION; CELLS; CELLS, CULTURED; EPITHELIAL CELLS; HUMANS; LYMPHOCRYPTOVIRUS; MACACA MULATTA; MEMBRANE PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; VIRAL MATRIX PROTEINS;

ANIMALIA; CERCOPITHECINE HERPESVIRUS 15; HERPESVIRIDAE; HUMAN HERPESVIRUS 4;

EID: 44949174077     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2008.03.033     Document Type: Article

References (25)

1. Alfandari J., Shnitman Magal S., Jackman A., Schlegel R., Gonen P., and Sherman L. HPV16 E6 oncoprotein inhibits apoptosis induced during serum-calcium differentiation of foreskin human keratinocytes. Virology 257 2 (1999) 383-396
2. Brazil D.P., and Hemmings B.A. Ten years of protein kinase B signalling: a hard Akt to follow. Trends Biochem. Sci. 26 11 (2001) 657-664
3. Cross D.A., Alessi D.R., Cohen P., Andjelkovich M., and Hemmings B.A. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378 6559 (1995) 785-789
4. Ding V.W., Chen R.H., and McCormick F. Differential regulation of glycogen synthase kinase 3beta by insulin and Wnt signaling. J. Biol. Chem. 275 42 (2000) 32475-32481
5. Farwell D.G., Shera K.A., Koop J.I., Bonnet G.A., Matthews C.P., Reuther G.W., Coltrera M.D., McDougall J.K., and Klingelhutz A.J. Genetic and epigenetic changes in human epithelial cells immortalized by telomerase. Am. J. Pathol. 156 5 (2000) 1537-1547
6. Feichtinger H., Putkonen P., Parravicini C., Li S.L., Kaaya E.E., Bottiger D., Biberfeld G., and Biberfeld P. Malignant lymphomas in cynomolgus monkeys infected with simian immunodeficiency virus. Am. J. Pathol. 137 6 (1990) 1311-1315
7. Feichtinger H., Kaaya E., Putkonen P., Li S.L., Ekman M., Gendelman R., Biberfeld G., and Biberfeld P. Malignant lymphoma associated with human AIDS and with SIV-induced immunodeficiency in macaques. AIDS Res. Hum. Retrovir. 8 3 (1992) 339-348
8. Fruehling S., and Longnecker R. The immunoreceptor tyrosine-based activation motif of Epstein-Barr virus LMP2A is essential for blocking BCR-mediated signal transduction. Virology 235 2 (1997) 241-251
9. Habis A., Baskin G.B., Murphey-Corb M., and Levy L.S. Simian AIDS-associated lymphoma in rhesus and cynomolgus monkeys recapitulates the primary pathobiological features of AIDS-associated non-Hodgkin's lymphoma. AIDS Res. Hum. Retrovir. 15 15 (1999) 1389-1398
10. Ikeda A., Caldwell R.G., Longnecker R., and Ikeda M. Itchy, a Nedd4 ubiquitin ligase, downregulates latent membrane protein 2A activity in B-cell signaling. J. Virol. 77 9 (2003) 5529-5534
11. Kutok J.L., Klumpp S., Simon M., MacKey J.J., Nguyen V., Middeldorp J.M., Aster J.C., and Wang F. Molecular evidence for rhesus lymphocryptovirus infection of epithelial cells in immunosuppressed rhesus macaques. J. Virol. 78 7 (2004) 3455-3461
12. Longnecker R., Miller C.L., Miao X.Q., Tomkinson B., and Kieff E. The last seven transmembrane and carboxy-terminal cytoplasmic domains of Epstein-Barr virus latent membrane protein 2 (LMP2) are dispensable for lymphocyte infection and growth transformation in vitro. J. Virol. 67 4 (1993) 2006-2013
13. Longnecker R., Miller C.L., Tomkinson B., Miao X.Q., and Kieff E. Deletion of DNA encoding the first five transmembrane domains of Epstein-Barr virus latent membrane proteins 2A and 2B. J. Virol. 67 8 (1993) 5068-5074
14. Moghaddam A., Rosenzweig M., Lee-Parritz D., Annis B., Johnson R.P., and Wang F. An animal model for acute and persistent Epstein-Barr virus infection. Science 276 5321 (1997) 2030-2033
15. Moghaddam A., Koch J., Annis B., and Wang F. Infection of human B lymphocytes with lymphocryptoviruses related to Epstein-Barr virus. J. Virol. 72 4 (1998) 3205-3212
16. Morrison J.A., and Raab-Traub N. Roles of the ITAM and PY motifs of Epstein-Barr virus latent membrane protein 2A in the inhibition of epithelial cell differentiation and activation of {beta}-catenin signaling. J. Virol. 79 4 (2005) 2375-2382
17. Morrison J.A., Klingelhutz A.J., and Raab-Traub N. Epstein-Barr virus latent membrane protein 2A activates beta-catenin signaling in epithelial cells. J. Virol. 77 22 (2003) 12276-12284
18. Morrison J.A., Gulley M.L., Pathmanathan R., and Raab-Traub N. Differential signaling pathways are activated in the Epstein-Barr virus-associated malignancies nasopharyngeal carcinoma and Hodgkin lymphoma. Cancer Res. 64 15 (2004) 5251-5260
19. Novak A., and Dedhar S. Signaling through beta-catenin and Lef/Tcf. Cell. Mol. Life Sci. 56 5-6 (1999) 523-537
20. Rickinson A., and Kieff E. Epstein-Barr virus. In: Knipe B.F.D., and Howley P. (Eds). Fields Virology (1996), Raven Press, Philadelphia 2397-2446
21. Rivailler P., Cho Y.G., and Wang F. Complete genomic sequence of an Epstein-Barr virus-related herpesvirus naturally infecting a new world primate: a defining point in the evolution of oncogenic lymphocryptoviruses. J. Virol. 76 23 (2002) 12055-12068
22. Scholle F., Bendt K.M., and Raab-Traub N. Epstein-Barr virus LMP2A transforms epithelial cells, inhibits cell differentiation, and activates Akt. J. Virol. 74 22 (2000) 10681-10689
23. Scholle F., Longnecker R., and Raab-Traub N. Analysis of the phosphorylation status of Epstein-Barr virus LMP2A in epithelial cells. Virology 291 2 (2001) 208-214
24. Swart R., Ruf I.K., Sample J., and Longnecker R. Latent membrane protein 2A-mediated effects on the phosphatidylinositol 3-kinase/Akt pathway. J. Virol. 74 22 (2000) 10838-10845
25. Yang L., Dan H.C., Sun M., Liu Q., Sun X.M., Feldman R.I., Hamilton A.D., Polokoff M., Nicosia S.V., Herlyn M., Sebti S.M., and Cheng J.Q. Akt/protein kinase B signaling inhibitor-2, a selective small molecule inhibitor of Akt signaling with antitumor activity in cancer cells overexpressing Akt. Cancer Res. 64 13 (2004) 4394-4399